By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a...
By Chris Wack Arcturus Therapeutics Holdings Inc. shares were up 31% to $24.03 after it entered into a strategic collaboration with CSL Seqirus...
By Josh Beckerman Arcturus Therapeutics Holdings Inc. shares rose 26% to $23.10 after hours as the company announced a vaccine collaboration with...
By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia's CSL Ltd. that...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland's...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. has made an all-cash offer for Vifor Pharma Ltd. that values the Swiss...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it is in talks with Vifor Pharma Ltd. over a potential acquisition of...
By Mike Cherney SYDNEY -- A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV...
By David Winning SYDNEY--CSL Ltd., Australia's largest pharmaceutical company, said it had signed initial deals for the supply of vaccines...
By Mike Cherney SYDNEY--Collections of blood plasma have fallen sharply in recent months because of the coronavirus pandemic, raising worries...
By Colin Kellaher CSL Ltd.'s (CSL.AU) CSL Behring unit Monday said it received orphan-drug exclusivity from the U.S. Food and Drug...
23:08 GMT [Dow Jones] CSL (CSL.AU), Australia's largest pharmaceuticals group, is nursing a cold from the flu-vaccines business it bought...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
